Page last updated: 2024-08-23

zidovudine and Minimal Disease, Residual

zidovudine has been researched along with Minimal Disease, Residual in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bangham, CRM; Cook, LB; Demontis, MA; Gillet, NA; Greiller, C; Melamed, A; Rowan, AG; Sagawe, S; Taylor, GP; Witkover, A	1

Other Studies

1 other study(ies) available for zidovudine and Minimal Disease, Residual

Article	Year
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma. International journal of hematology, 2018, Volume: 107, Issue:3 Topics: Adult; Allografts; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm, Residual; Remission Induction; Time Factors; Zidovudine	2018

Article

Year

Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.

International journal of hematology, 2018, Volume: 107, Issue:3

Topics: Adult; Allografts; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm, Residual; Remission Induction; Time Factors; Zidovudine

2018